Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 8/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | MPO | P05164 | 3/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | HTR2C | P28335 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | HTR1D | P28221 | 3/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | HTR1B | P28222 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.61 |
| ▸ | SPR | P35270 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | IDO1 | P14902 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14907374 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL25076883 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL25076703 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL23633206 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL23630275 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL25076884 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL23633204 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL25076891 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL23630278 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C | |
| SCHEMBL27514454 | 0.99 | TRPV1 (0.69) | TRPV1KDM4EMPOCYP2D6HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0983060-A4 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2002-04-24 | — | — | EP | claimed |
| US-20020039594-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX THERAPEUTICS, INC. | 2002-04-04 | — | — | US | claimed |
| EP-0983060-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-08 | — | — | EP | claimed |
| WO-1998051282-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | claimed |
| WO-2024008341-A1 | SEROTONIN ANALOGUES FOR USE IN TREATING METALLOPTOSIS-ASSOCIATED DISORDERS | INSTITUT CURIE (FR) | 2024-01-11 | — | — | WO | disclosed |
| WO-2023021112-A1 | NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-02-23 | — | — | WO | disclosed |
| US-20120021036-A1 | COMPOSITE NANOSTRUCTURES AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-01-26 | — | — | US | disclosed |
| US-20120021914-A1 | Cyclodextrin-containing suspension concentrates, method for producing the same and their use | BASF SE (DE) | 2012-01-26 | — | — | US | disclosed |
| WO-2010083337-A2 | COMPOSITE NANOSTRUCTURES AND METHODS FOR MAKING AND USING THEM | THE REGENTS OF THE UNIVERSITY OF CALIFORINIA (US) | 2010-07-22 | — | — | WO | disclosed |
| US-20080319375-A1 | Materials, Methods, and Systems for Cavitation-mediated Ultrasonic Drug Delivery in vivo | BIOVALUATION & ANALYSIS, INC. | 2008-12-25 | — | — | US | disclosed |
| WO-2008157422-A1 | MATERIALS, METHODS, AND SYSTEMS FOR CAVITATION-MEDIATED ULTRASONIC DRUG DELIVERY | HARDY CHARLES THOMAS (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20080312581-A1 | Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo | BIOVALUATION & ANALYSIS, INC. | 2008-12-18 | — | — | US | disclosed |
| EP-0983060-A4 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2002-04-24 | — | — | EP | disclosed |
| EP-0981333-A4 | NOVEL ACOUSTICALLY ACTIVE DRUG DELIVERY SYSTEMS | IMARX PHARMACEUTICAL CORP (US) | 2002-04-24 | — | — | EP | disclosed |
| US-20020039594-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX THERAPEUTICS, INC. | 2002-04-04 | — | — | US | disclosed |
| US-20010018072-A1 | Solid matrix therapeutic compositions | IMARX THERAPEUTICS, INC. | 2001-08-30 | — | — | US | disclosed |
| EP-0983060-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-08 | — | — | EP | disclosed |
| EP-0981333-A1 | NOVEL ACOUSTICALLY ACTIVE DRUG DELIVERY SYSTEMS | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998051282-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998051284-A1 | NOVEL ACOUSTICALLY ACTIVE DRUG DELIVERY SYSTEMS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312581-A1 | Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo | MYOC, PITRM1, VIP | TRPV1 873/4885KDM4E 4820/4885MPO 4204/4885 |
| US-20120021914-A1 | Cyclodextrin-containing suspension concentrates, method for producing the same and their use | GYS2, DCXR, ADH1C | TRPV1 4389/4885KDM4E 2863/4885MPO 2795/4885 |
| US-20020039594-A1 | SOLID POROUS MATRICES AND METHODS OF MAKING AND USING THE SAME | EXOSC9, EXOSC5, EXOSC4 | TRPV1 1408/4885KDM4E 1279/4885MPO 1354/4885 |
| US-20010018072-A1 | Solid matrix therapeutic compositions | MMP7, MMP1, MMP17 | TRPV1 3939/4885KDM4E 3658/4885MPO 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.